4 Einträge gefunden

1. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer:SafeHer phase III study's primary analysis of 2573 patients

   1. Gligorov, J
   2. Ataseven, B
   3. Verrill, M
   4. De Laurentiis, M
   5. Jung, K H
   6. Azim, H A
   7. Al-Sakaff, N

   2017 - Forschungsinformationssystem des UKE
2. Subcutaneous Trastuzumab for HER2-positive Breast Cancer - Evidence and Practical Experience in 7 German Centers

   1. Jackisch, C
   2. Müller, V
   3. Dall, P
   4. Neumeister, R
   5. Park-Simon, T-W
   6. Ruf-Dördelmann, A
   7. Seiler, S

   2015 - Forschungsinformationssystem des UKE
3. Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy

   1. Lindner, J L
   2. Loibl, S
   3. Denkert, C
   4. Ataseven, B
   5. Fasching, P A
   6. Pfitzner, B M
   7. Gerber, B

   2015 - Forschungsinformationssystem des UKE
4. Subcutaneous Administration of Monoclonal Antibodies in Oncology

   1. Jackisch, C
   2. Müller, V
   3. Maintz, C
   4. Hell, S
   5. Ataseven, B

   2014 - Forschungsinformationssystem des UKE